As the condition worsens, common symptoms include: weakness and fatigue light-headedness and dizziness palpitations and rapid heartbeat shortness of breath a sore tongue that has a red, beefy appearance nausea or poor appetite weight loss diarrhea yellowish tinge to the skin and eyes
Clinical trial evidence: An analysis of several clinical trials for weight loss, people taking semaglutide 2.4 mg had similar rates of anxiety and other mental health issues as those taking a placebo
However, enzyme supplements may cause their own gastrointestinal side effects that can overlap with GLP-1-related symptoms, and some formulations containing bromelain or papain may interact with anticoagulants
Additionally, C-incubation time (min) demonstrates a moderate effect with a p-value of 0.0284
The LEADER-derived CV risk prediction model predicted CV risk in the semaglutide data satisfactorily (the AUC [95% CI] of 0.77 [0.74;0.79] indicated a fair predictive performance [32]
A few successfully discontinue and maintain results through lifestyle changes alone